Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Village Global Podcast

A Deep Dive on SBIRs with Ben Van Roo

20 Oct 2022

Description

Ben Van Roo (@DavidNorthStar), co-founder and CEO of Yurts AI, joins Lucas Bagno on this episode of Solarpunk. Takeaways:- The Small Business Innovation Research program was originally developed as a grant program to allow small companies do innovative research. The gene for cystic fibrosis was discovered from the program.- If you’re a small company and you get an SBIR contract, you should not count on getting a government contract.- It has been very difficult for software companies to get a program of record contract because that has not been the typical model of defense in the past.- The nature of war is shifting away from large platforms and big garrison-style bases.- There have been 20-30 “SBIR mills” that have taken $3.5B combined in phase 1 and 2 contracts. Ben would put hard caps on the amounts that companies can get from the program and the types of companies that can apply to the SBIR program.- Commercial technology has outpaced the defense industry by far.- It’s very difficult for small companies to even fill out the forms required for the SBIR program. Making it more friendly for newcomers would make a big difference to the program.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform.Check us out on the web at www.villageglobal.vc or get in touch with us on Twitter @villageglobal.Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. www.villageglobal.vc/signup

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.